Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 58476 - 58500 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Perflubron	Investigational	HSD17B1	3292	upregulated	perflubron results in increased expression of HSD17B1 mRNA	17q21.2	A21727
Perflubron	Investigational	HSD3B2	3284	upregulated	perflubron results in increased expression of HSD3B2 mRNA	1p12	A21727
Perflubron	Investigational	STAR	6770	upregulated	perflubron results in increased expression of STAR mRNA	8p11.23	A21727
Perfosfamide	Investigational	FASLG	356	upregulated	perfosfamide results in increased expression of FASLG mRNA	1q24.3	A23592
Perhexiline	Approved	AP1S1	1174	downregulated	Perhexiline results in decreased expression of AP1S1 mRNA	7q22.1	A20430
Perhexiline	Approved	ASAH1	427	upregulated	Perhexiline results in increased expression of ASAH1 mRNA	8p22	A20438 A20430
Perhexiline	Approved	ASNS	440	upregulated	Perhexiline results in increased expression of ASNS mRNA	7q21.3	A20430
Perhexiline	Approved	FABP1	2168	upregulated	Perhexiline results in increased expression of FABP1 mRNA	2p11.2	A20438 A20430
Perhexiline	Approved	FNDC4	64838	upregulated	Perhexiline results in increased expression of FNDC4 mRNA	2p23.3	A20438 A20430
Perhexiline	Approved	GDPD3	79153	upregulated	Perhexiline results in increased expression of GDPD3 mRNA	16p11.2	A20438 A20430
Perhexiline	Approved	HPN	3249	upregulated	Perhexiline results in increased expression of HPN mRNA	19q13.11	A20438 A20430
Perhexiline	Approved	INHBE	83729	upregulated	Perhexiline results in increased expression of INHBE mRNA	12q13.3	A20430
Perhexiline	Approved	LSS	4047	upregulated	Perhexiline results in increased expression of LSS mRNA	21q22.3	A20438 A20430
Perhexiline	Approved	NR0B2	8431	upregulated	Perhexiline results in increased expression of NR0B2 mRNA	1p36.11	A20438 A20430
Perhexiline	Approved	NUPR1	26471	upregulated	Perhexiline results in increased expression of NUPR1 mRNA	16p11.2	A20430
Perhexiline	Approved	SERPINA3	12	upregulated	Perhexiline results in increased expression of SERPINA3 mRNA	14q32.13	A20438 A20430
Perhexiline	Approved	SLC2A3	6515	downregulated	Perhexiline results in decreased expression of SLC2A3 mRNA	12p13.31	A20438
Perhexiline	Approved	SLC2A3	6515	upregulated	Perhexiline results in increased expression of SLC2A3 mRNA	12p13.31	A20430
Perhexiline	Approved	TAGLN	6876	downregulated	Perhexiline results in decreased expression of TAGLN mRNA	11q23.2	A20438 A20430
Perhexiline	Approved	WIPI1	55062	upregulated	Perhexiline results in increased expression of WIPI1 mRNA	17q24.2	A20438 A20430
Permethrin	Approved Investigational	CYP1A1	1543	upregulated	Permethrin results in increased expression of CYP1A1 mRNA	15q24.1	A23593 A21551
Permethrin	Approved Investigational	CYP1A2	1544	upregulated	Permethrin results in increased expression of CYP1A2 mRNA	15q24.1	A21551
Permethrin	Approved Investigational	CYP2A6	1548	upregulated	Permethrin results in increased expression of CYP2A6 mRNA	19q13.2	A23593
Permethrin	Approved Investigational	CYP2B6	1555	upregulated	Permethrin results in increased expression of CYP2B6 mRNA	19q13.2	A23593
Permethrin	Approved Investigational	CYP3A4	1576	upregulated	Permethrin results in increased expression of CYP3A4 mRNA	7q22.1	A23594 A23593

Displaying entries 58476 - 58500 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability